| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8657260 | Atherosclerosis Supplements | 2017 | 6 Pages |
Abstract
MP is a viable option for lipid-lowering therapy in statin-intolerant patients with hypercholesterolaemia, with good efficacy and safety profiles.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Claudia Stefanutti, Fabio Mazza, Dario Mesce, Claudia Morozzi, Serafina Di Giacomo, Marco Vitale, Mario Pergolini,